Cargando…

The effect of vitamin K on prothrombin time in critically ill patients: an observational registry study

BACKGROUND: Previous studies have indicated that vitamin K deficiency is common in non-bleeding critically ill patients with slightly prolonged prothrombin time-international normalized ratio (PT-INR). It has never been investigated thoroughly whether the administration of vitamin K to these patient...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dahlberg, Sofia, Schött, Ulf, Kander, Thomas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7814614/ https://www.ncbi.nlm.nih.gov/pubmed/33461606 http://dx.doi.org/10.1186/s40560-020-00517-5

Ejemplares similares

Intravenous Vitamin K1 for the Correction of Prolonged Prothrombin Times in Non-Bleeding Critically Ill Patients: A Prospective Observational Study
por: Dahlberg, Sofia, et al.
Publicado: (2021)

Vitamin K Effects on Gas6 and Soluble Axl Receptors in Intensive Care Patients: An Observational Screening Study
por: Schött, Ulf, et al.
Publicado: (2021)

Assessment of Haemostasis in Disseminated Intravascular Coagulation by Use of Point-of-Care Assays and Routine Coagulation Tests, in Critically Ill Patients; A Prospective Observational Study
por: Kander, Thomas, et al.
Publicado: (2016)

Dose-response effects of omega-3 on platelet aggregation: an observational study
por: Kander, Thomas, et al.
Publicado: (2018)

Desphospho-Uncarboxylated Matrix-Gla Protein Is Increased Postoperatively in Cardiovascular Risk Patients
por: Dahlberg, Sofia, et al.
Publicado: (2018)

Evaluation of Prothrombin Response to Vitamin K as Liver Function Test
por: Wahi, P. N.
Publicado: (1947)

Influence of prothrombin complex concentrates on plasma coagulation in critically ill patients
por: Staudinger, T., et al.
Publicado: (1999)

Effect of hypothermia on haemostasis and bleeding risk: a narrative review
por: Kander, Thomas, et al.
Publicado: (2019)

Progression of Prothrombin Induced by Vitamin K Absence-II in Hepatocellular Carcinoma
por: Yang, Yang, et al.
Publicado: (2021)

Morbidity and mortality in critically ill patients with invasive group A streptococcus infection: an observational study
por: Björck, Viveka, et al.
Publicado: (2020)

Synergistic platelet inhibition between Omega-3 and acetylsalicylic acid dose titration; an observational study
por: Bagger, Harald, et al.
Publicado: (2020)

BLEEDING TENDENCY AND PROTHROMBIN DEFICIENCY IN BILIARY FISTULA DOGS: EFFECT OF FEEDING BILE AND VITAMIN K
por: Smith, H. P., et al.
Publicado: (1938)

A novel prothrombin time method to measure all non-vitamin K-dependent oral anticoagulants (NOACs)
por: Lindahl, Tomas L., et al.
Publicado: (2017)

Effects of Dextran-70 and Albumin on Coagulation in Experimental Hemorrhage in the Guinea Pig
por: Schött, Ulf, et al.
Publicado: (2018)

Platelet aggregation and clot formation in comatose survivors of cardiac arrest treated with induced hypothermia and dual platelet inhibition with aspirin and ticagrelor; a prospective observational study
por: Kander, Thomas, et al.
Publicado: (2014)

The precision of ROTEM EXTEM is decreased in hypocoagulable blood: a prospective observational study
por: Sunnersjö, Lotta, et al.
Publicado: (2023)

Effects of naturopathic medicines on Multiplate and ROTEM: a prospective experimental pilot study in healthy volunteers
por: Bagge, August, et al.
Publicado: (2016)

Safety and efficacy of a strategy of vitamin K antagonist reversal with prothrombin complex concentrates compared to vitamin K in patients with hip fracture
por: Jay-Caillierez, Lucille, et al.
Publicado: (2021)

ABO and RhD blood group are not associated with mortality and morbidity in critically ill patients; a multicentre observational study of 29 512 patients
por: Kander, Thomas, et al.
Publicado: (2022)

Prothrombin time is predictive of low plasma prothrombin concentration and clinical outcome in patients with trauma hemorrhage: analyses of prospective observational cohort studies
por: Balendran, Clare A., et al.
Publicado: (2017)

Reversal of Vitamin K Antagonist Therapy by Prothrombin Complex Concentrate before Thrombolysis for Acute Stroke
por: Chausson, Nicolas, et al.
Publicado: (2013)

Efficacy and safety of activated prothrombin complex concentrate for the reversal of vitamin K antagonist major bleeding
por: Sheikh-Taha, Marwan, et al.
Publicado: (2022)

The progress of prothrombin time measurement
por: Horsti, Juha
Publicado: (2009)

Prothrombin Time in Normal Indians
por: Braganca, Beatriz M., et al.
Publicado: (1946)

Clinical outcome of patients with a vitamin K antagonist‐associated bleeding treated with prothrombin complex concentrate
por: Brekelmans, Marjolein P. A., et al.
Publicado: (2017)

Use of Prothrombin Complex Concentrate for Vitamin K Antagonist Reversal before Surgical Treatment of Intracranial Hemorrhage
por: Wong, Yun
Publicado: (2011)

Optimal Dosage and Administration Practices for Vitamin K Antagonist Reversal With 4-Factor Prothrombin Complex Concentrate
por: Rhoney, Denise H., et al.
Publicado: (2020)

Prothrombin complex concentrate in surgical patients: retrospective evaluation of vitamin K antagonist reversal and treatment of severe bleeding
por: Schick, Kerstin S, et al.
Publicado: (2009)

Factors contributing to poor outcome in patients on warfarin receiving 4-factor prothrombin complex concentrate in critically ill
por: Mishra, Ajay Kumar, et al.
Publicado: (2021)

The Effect of Sugammadex on Prothrombin and Activated Partial Thromboplastin Time
por: Samara, Evangelia, et al.
Publicado: (2021)

A national study of plasma use in critical care: clinical indications, dose and effect on prothrombin time
por: Stanworth, Simon J, et al.
Publicado: (2011)

Guideline-concordant administration of prothrombin complex concentrate and vitamin K is associated with decreased mortality in patients with severe bleeding under vitamin K antagonist treatment (EPAHK study)
por: Tazarourte, Karim, et al.
Publicado: (2014)

Appropriateness of Using Vitamin K for the Correction of INR Elevation Secondary to Hepatic Disease in Critically ill Patients: An Observational Study
por: Al Sulaiman, Khalid, et al.
Publicado: (2021)

Critically ill COVID-19 patients in Africa: it is time for quality registry data
por: Pisani, Luigi, et al.
Publicado: (2021)

Clinical Significance of Prothrombin Time in Cholangiocarcinoma Patients with Surgeries
por: Wang, Hui-shan, et al.
Publicado: (2019)

Reversal of Vitamin K Antagonist (VKA) effect in patients with severe bleeding: a French multicenter observational study (Optiplex) assessing the use of Prothrombin Complex Concentrate (PCC) in current clinical practice
por: Desmettre, Thibaut, et al.
Publicado: (2012)

New artificial intelligence prediction model using serial prothrombin time international normalized ratio measurements in atrial fibrillation patients on vitamin K antagonists: GARFIELD-AF
por: Goto, Shinichi, et al.
Publicado: (2019)

The effect of nutrition and severity of illness on blood vitamin concentrations in critically ill patients
por: Hill, SE, et al.
Publicado: (1997)

Increased risk of volume overload with plasma compared with four‐factor prothrombin complex concentrate for urgent vitamin K antagonist reversal
por: Refaai, Majed A., et al.
Publicado: (2015)

Fixed Versus Variable Dosing of Prothrombin Complex Concentrate in Vitamin K Antagonist-Related Intracranial Hemorrhage: A Retrospective Analysis
por: Abdoellakhan, Rahat Amadkhan, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_b5plds8ldnusehc88ri84u7oho